You have 9 free searches left this month | for more free features.

Window of Opportunity Clinical Trials

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Renal Cell Cancer Trial in Cambridge (Olaparib, Cediranib, Durvalumab)

Recruiting
  • Renal Cell Cancer
  • Cambridge, England, United Kingdom
    Addenbrooke's Hospital
May 21, 2021

Breast Cancer Trial in Ottawa, Toronto (Arm A: Cemiplimab, Arm B: Cemiplimab + Dupilumab)

Not yet recruiting
  • Breast Cancer
  • Arm A: Cemiplimab, Arm B: Cemiplimab + Dupilumab
  • Ottawa, Ontario, Canada
  • +1 more
Jul 22, 2023

Breast Cancer Trial (GSK3326595)

Completed
  • Breast Cancer
  • London, Ontario, Canada
    St. Joseph's Health Care London
Oct 24, 2022

Prostate Cancer Trial in Norwich (Allin, Sulforaphane, Placebo)

Completed
  • Prostate Cancer
  • Allin
  • +2 more
  • Norwich, Norfolk, United Kingdom
    Quadram Institute Bioscience
Nov 17, 2020

Primary Brain Tumor, Brain Tumor, Recurrent Trial in Durham (Fluoxetine, Temozolomide)

Not yet recruiting
  • Primary Brain Tumor
  • Brain Tumor, Recurrent
  • Durham, North Carolina
    The Preston Robert Tisch Brain Tumor Center at Duke University
Dec 20, 2022

Head Neck Cancer, Head and Neck Tumors Trial run by the NCI (M7824, N803, TriAd vaccine)

Active, not recruiting
  • Head and Neck Cancer
  • Head and Neck Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 26, 2023

Oral Cancer Trial in Charleston (Imiquimod 5% Cream,Top,Pkt,0.25Gm)

Recruiting
  • Oral Cancer
  • Imiquimod 5% Cream,Top,Pkt,0.25Gm
  • Charleston, South Carolina
    Medical University of South Carolina
May 10, 2022

Breast Cancer Trial in Ottawa (INT230-6, Saline injection)

Recruiting
  • Breast Cancer
  • Ottawa, Ontario, Canada
    The Ottawa Hospital Research Institute and Cancer Center
Nov 9, 2021

Triple Negative Breast Cancer Trial in Lausanne (stereotactic body radiotherapy, CMP-001)

Recruiting
  • Triple Negative Breast Cancer
  • stereotactic body radiotherapy
  • CMP-001
  • Lausanne, Vaud, Switzerland
    CHUV Oncology Department
Jul 6, 2021

Recurrent Gliosarcoma, Recurrent Supratentorial Glioblastoma, Supratentorial Gliosarcoma Trial in Houston (Cord Blood-derived

Not yet recruiting
  • Recurrent Gliosarcoma
  • +2 more
  • Cord Blood-derived Expanded Allogeneic Natural Killer Cells
  • Resection
  • Houston, Texas
    M D Anderson Cancer Center
May 24, 2022

HPV 16+ Confirmed Oropharynx Cancer and Cervical Cancer Trial in Milwaukee (HB-201 IT, HB-201 IV)

Recruiting
  • HPV 16+ Confirmed Oropharynx Cancer and Cervical Cancer
  • HB-201 IT
  • HB-201 IV
  • Milwaukee, Wisconsin
    Froedtert Hospital and the Medical College of Wisconsin
Jul 28, 2022

Undifferentiated Pleomorphic Sarcoma Trial in Iowa City (Palbociclib, Pembrolizumab)

Not yet recruiting
  • Undifferentiated Pleomorphic Sarcoma
  • Iowa City, Iowa
    University of Iowa Hospitals & Clinics
Nov 1, 2023

Breast Cancer Trial in Barcelona, Lleida, Tarragona (Onapristone)

Completed
  • Breast Cancer
  • Barcelona, Spain
  • +3 more
Mar 31, 2022

Colorectal Carcinoma (CRC), Endometrial Carcinoma (EC) Trial in Oklahoma City (TPST-1495)

Not yet recruiting
  • Colorectal Carcinoma (CRC)
  • Endometrial Carcinoma (EC)
  • Oklahoma City, Oklahoma
    Stephenson's Cancer Center
Nov 8, 2023

Endometrial Cancer, Uterine Cancer Trial in Chapel Hill (Pembrolizumab, Hysterectomy)

Recruiting
  • Endometrial Cancer
  • Uterine Cancer
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center
Sep 27, 2022

NSCLC Trial in Iowa City (Durvalumab, Pharmacological ascorbate, Surgery (SOC))

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Iowa City, Iowa
    University of Iowa
Oct 10, 2023

Bladder Cancer Trial in Chapel Hill, Philadelphia (Pembrolizumab, Entinostat)

Recruiting
  • Bladder Cancer
  • Chapel Hill, North Carolina
  • +1 more
Oct 10, 2022

Multiple Myeloma Trial (Linvoseltamab)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Apr 12, 2023

Differentiated Thyroid Cancer Trial in Pavia (Pembrolizumab)

Not yet recruiting
  • Differentiated Thyroid Cancer
  • Pavia, Lombardia, Italy
    Istituti Clinici Scientifici Maugeri
May 5, 2023

Early Breast Cancer Trial in Worldwide (Giredestrant, Anastrozole, Palbociclib)

Completed
  • Early Breast Cancer
  • Beverly Hills, California
  • +73 more
Jan 5, 2022

Squamous Cell Carcinoma of the Oral Cavity or Oropharynx Trial (Black Raspberry)

Not yet recruiting
  • Squamous Cell Carcinoma of the Oral Cavity or Oropharynx
  • Black Raspberry
  • (no location specified)
Oct 16, 2023

Breast Cancer, Triple Negative Breast Cancer Trial in Gothenburg (Imatinib 400 MG Oral Tablet)

Not yet recruiting
  • Breast Cancer
  • Triple Negative Breast Cancer
  • Imatinib 400 MG Oral Tablet
  • Gothenburg, Sweden
    Barbro Linderholm
Feb 1, 2023

Breast Cancer, Breast Cancer, Early-Onset Trial (Giredestrant, Tamoxifen)

Not yet recruiting
  • Breast Cancer
  • Breast Cancer, Early-Onset
  • (no location specified)
Jan 18, 2023

Squamous Cell Carcinoma of the Oral Cavity Trial in Milwaukee (Antitumor B KAC)

Not yet recruiting
  • Squamous Cell Carcinoma of the Oral Cavity
  • Antitumor B KAC
  • Milwaukee, Wisconsin
    Froedtert Hospital and the Medical College of Wisconsin
Jul 6, 2022